| 臺大學術典藏 |
2021-05-31T02:56:48Z |
Fracture types affect clinical outcomes of patients managed within the fracture liaison and osteoporosis medication management services
|
Chang C.-B.;Rong-Sen Yang;Chang L.-Y.;Peng J.-K.;Tsai K.-S.;Huang W.-J.;Yang T.-H.;Chan D.-C.; Chang C.-B.; RONG-SEN YANG; Chang L.-Y.; Peng J.-K.; Tsai K.-S.; Huang W.-J.; Yang T.-H.; Chan D.-C. |
| 臺大學術典藏 |
2021-05-31T02:56:45Z |
One-year outcomes of an osteoporosis liaison services program initiated within a healthcare system
|
Chang C.-B.; RONG-SEN YANG; Chang L.-Y.; Peng J.-K.; Tsai K.-S.; Huang W.-J.; Yang T.-H.; Chan D.-C. |
| 臺大學術典藏 |
2021-05-31T02:56:45Z |
Application of deep learning algorithm to detect and visualize vertebral fractures on plain frontal radiographs
|
Chen H.-Y.; Hsu B.W.-Y.; Yin Y.-K.; Lin F.-H.; Yang T.-H.; RONG-SEN YANG; Lee C.-K.; Tseng V.S. |
| 臺大學術典藏 |
2021-05-31T02:56:44Z |
Bone Cement Implantation Syndrome in Bone Tumor Surgeries: Incidence, Risk Factors, and Clinical Experience
|
Yang T.-H.; RONG-SEN YANG; Lin C.-P.; Tseng T.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:40Z |
Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway
|
Chiu C.-Y.;Yang R.-S.;Sheu M.-L.;Chan D.-C.;Yang T.-H.;Tsai K.-S.;Chih-Kang Chiang;Liu S.-H.; Chiu C.-Y.; Yang R.-S.; Sheu M.-L.; Chan D.-C.; Yang T.-H.; Tsai K.-S.; CHIH-KANG CHIANG; Liu S.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:38Z |
Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation
|
Chen Y.-J.;Chan D.-C.;Chih-Kang Chiang;Wang C.-C.;Yang T.-H.;Lan K.-C.;Chao S.-C.;Tsai K.-S.;Yang R.-S.;Liu S.-H.; Chen Y.-J.; Chan D.-C.; CHIH-KANG CHIANG; Wang C.-C.; Yang T.-H.; Lan K.-C.; Chao S.-C.; Tsai K.-S.; Yang R.-S.; Liu S.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:38Z |
The pathological role of advanced glycation end productsdownregulated heat shock protein 60 in islet β-cell hypertrophy and dysfunction
|
Guan S.-S.;Sheu M.-L.;Yang R.-S.;Chan D.-C.;Wu C.-T.;Yang T.-H.;Chih-Kang Chiang;Liu S.-H.; Guan S.-S.; Sheu M.-L.; Yang R.-S.; Chan D.-C.; Wu C.-T.; Yang T.-H.; CHIH-KANG CHIANG; Liu S.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:28Z |
Prevention of acute kidney injury by low intensity pulsed ultrasound via anti-inflammation and anti-apoptosis
|
Chih-Kang Chiang;Loh J.-Z.;Yang T.-H.;Huang K.-T.;Wu C.-T.;Guan S.-S.;Liu S.-H.;Hung K.-Y.; CHIH-KANG CHIANG; Loh J.-Z.; Yang T.-H.; Huang K.-T.; Wu C.-T.; Guan S.-S.; Liu S.-H.; Hung K.-Y. |
| 臺大學術典藏 |
2021-05-27T08:21:02Z |
Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria
|
Hsu Y.-C.; JYH-MING LIOU; Liao S.-C.; Yang T.-H.; Wu H.-T.; Hsu W.-L.; Lin H.-J.; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:21:00Z |
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: Is therapeutic response predicted by Rome III subgroups?
|
Hsu Y.-C.; JYH-MING LIOU; Yang T.-H.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:59Z |
Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?
|
Hsu Y.-C.; Yang T.-H.; JYH-MING LIOU; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:53Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; JYH-MING LIOU; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:53Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
JYH-MING LIOU; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
JYH-MING LIOU; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
JYH-MING LIOU; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; JYH-MING LIOU; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
JYH-MING LIOU; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:42Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-07T05:13:24Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHING-CHOW CHEN; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; CHING-CHOW CHEN; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-29T06:08:21Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou, J.-M.; Chen, C.-C.; Chang, C.-M.; Fang, Y.-J.; Bair, M.-J.; Chen, P.-Y.; Chang, C.-Y.; Hsu, Y.-C.; Chen, M.-J.; Chen, C.-C.; Lee, J.-Y.; Yang, T.-H.; Luo, J.-C.; Chen, C.-Y.; Hsu, W.-F.; Chen, Y.-N.; Wu, J.-Y.; Lin, J.-T.; Lu, T.-P.; Chuang, E.Y.; El-Omar, E.M.; Wu, M.-S.; ERIC YAO-YU CHUANG |
| 臺大學術典藏 |
2021-03-18T02:03:48Z |
Serum pepsinogen I, II, and the ratio of pepsinogen I / pepsinogen II in the intestinal metaplasia of the stomach
|
Chang S.-Y.;Wu M.-S.;Chia-Tung Shun;Wang H.-H.;Yang T.-H.;Liu C.-Y.;Lin J.- T.; Chang S.-Y.; Wu M.-S.; CHIA-TUNG SHUN; Wang H.-H.; Yang T.-H.; Liu C.-Y.; Lin J.- T. |
| 臺大學術典藏 |
2021-03-18T02:02:40Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:35Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease and Helicobacter Consortium |
